MetaCap

Who Owns Rapport Therapeutics Stock?

NASDAQ: RAPPHealth CareBiotechnology: Pharmaceutical PreparationsUSD

23.16-0.43 (-1.82%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
86.38%
Institutional holders
226
  • Institutions 86.4%
  • Insiders 3.2%
  • Public and other 10.5%

Who owns Rapport Therapeutics stock?

Institutional investors own about 86.4% of Rapport Therapeutics's shares, spread across 226 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 3.17% of RAPP.

The largest institutional holders are FMR, LLC (12.14%), Trv Gp V, LLC (10.59%) and Arch Venture Management, Llc (6.29%). Together, the top 10 institutions control 56.5% of shares outstanding. In their latest filings, 3 of the top 10 institutions increased their RAPP positions and 3 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of RAPP

Rapport Therapeutics top institutional holders
InstitutionShares% HeldChange
FMR, LLC7.20M12.14%+0.3%
Trv Gp V, LLC 6.28M10.59%0.0%
Arch Venture Management, Llc3.73M6.29%0.0%
Goldman Sachs Group Inc2.97M5.02%+2.2%
Blackrock Inc.2.88M4.86%+6.7%
Capital International Investors2.65M4.48%-9.2%
Cormorant Asset Management, LP2.46M4.15%-7.5%
Sofinnova Investments, Inc.1.90M3.21%0.0%
Johnson & Johnson1.78M3.01%0.0%
Polar Capital Holdings PLC1.60M2.71%-0.3%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of RAPP

Rapport Therapeutics top fund holders
FundShares% Held
SmallCap World Fund Inc3.12M5.26%
Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund2.32M3.92%
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund986.73K1.66%
iShares Trust-iShares Russell 2000 ETF793.83K1.34%
Fidelity Mt. Vernon Street Trust-Fidelity Growth Company K6 Fund703.00K1.19%
Fidelity Mt. Vernon Street Trust-Fidelity Series Growth Company Fund603.31K1.02%
T. Rowe Price Health Sciences Fund, Inc.571.90K0.96%
Fidelity Salem Street Trust-Fidelity Small Cap Index Fund335.42K0.57%
Fidelity Select Portfolios-Select Biotechnology Portfolio332.16K0.56%
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund328.60K0.55%

Frequently asked questions

Who is the largest shareholder of Rapport Therapeutics?

FMR, LLC is the largest institutional shareholder of RAPP, owning 12.14% of shares outstanding (7.20M shares) as of its latest 13F filing.

What percentage of Rapport Therapeutics is owned by institutions?

Institutions own about 86.4% of RAPP shares and 89.2% of the public float.

How much of Rapport Therapeutics do insiders own?

Insiders, such as officers and directors, own about 3.17% of RAPP shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related